Current Roles in Cancer Diagnosis and Patient Management
Harvard Molecular Diagnostics Current Roles in Cancer Diagnosis and Patient Management focused on cutting-edge molecular techniques used in cancer diagnosis, prognosis, and patient management. Topics included next-generation sequencing (NGS), variant interpretation, cost-effective testing strategies, billing complexities, and the use of emerging biomarkers in both adult and pediatric oncology. With content delivered by world-renowned experts, the program offered participants up-to-date, clinically relevant knowledge for enhancing patient care.
* Original Release Date: September 13-16, 2021
LEARNING OBJECTIVES
Upon completion of this activity, participants will be able to:
Understand the fundamental principles and clinical applications of molecular diagnostics in oncology.
Apply knowledge of next-generation sequencing (NGS) and other molecular assays in cancer detection and management.
Interpret genetic variants effectively and translate test results into actionable clinical decisions.
Identify cost-effective diagnostic strategies and navigate billing and reimbursement processes.
Recognize emerging biomarkers and their potential roles in improving cancer diagnosis and treatment outcomes.
Integrate advanced molecular diagnostics into routine clinical practice to enhance patient care and precision medicine approaches.
HARVARD MOLECULAR DIAGNOSTICS CURRENT ROLES IN CANCER DIAGNOSIS AND PATIENT MANAGEMENT